Skip to main content

Infantile Epileptic Spasms Syndrome clinical trials at UCLA

1 research study open to eligible people

Showing trials for
  • Prevent Infantile Spasms Relapse

    open to eligible people ages 2 months to 18 months

    After initially successful treatment, many children with infantile spasms unfortunately have a relapse, and relapse is linked to poor long-term outcomes such as autism and other forms of epilepsy. The aim of this study is to determine if treatment with low-dose prednisolone is safe, well tolerated, and effective in reducing the risk of relapse.

    Los Angeles, California

Our lead scientists for Infantile Epileptic Spasms Syndrome research studies include .

Last updated: